Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

Clinical trial NCT07447817 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07447817
Sponsor: John Mascarenhas
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2026-05-04
Primary completion: 2030-05-24
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.